This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Fungal Diversity Open Access 12 July 2023
Herz Open Access 22 April 2022
Scientific Reports Open Access 25 March 2020
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Endo, A., Kuroda, M. & Tsujita, Y. ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinum. J. Antibiot. (Tokyo) 29, 1346–1348 (1976).
Endo, A., Kuroda, M. & Tanzawa, K. Competitive inhibition of 3-hydroxy-3- methylglutaryl coenzyme A reductase by ML-236A and ML 236B fungal metabolites, having hypocholesterolemic activity. FEBS Lett. 72, 323–326 (1976).
Endo, A., Tsujita, Y., Kuroda, M. & Tanzawa, K. Effects of ML-236B on cholesterol metabolism in mice and rats: lack of hypocholesterolemic activity in normal animals. Biochim. Biophys. Acta 575, 266–276 (1979).
Tsujita, Y., Kuroda, M., Tanzawa, K., Kitano, N. & Endo, A. Hypolipidemic effects in dogs of ML-236B, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Atherosclerosis 32, 307–313 (1979).
Endo, A. The discovery and development of HMG-CoA reductase inhibitors. J. Lipid Res. 33, 1569–1582 (1992).
Steinberg, D. An interpretative history of the cholesterol controversy. V. The discovery of the statins and the end of the controversy. J. Lipid Res. 47, 1339–1351 (2006).
Yamamoto, A., Sudo, H. & Endo, A. Therapeutic effects of ML-236B in primary hypercholesterolemia. Atherosclerosis 35, 259–266 (1980).
Alberts, A.W. et al. Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. Proc. Natl. Acad. Sci. USA 77, 3957–3961 (1980).
Mabuchi, H. et al. Effects of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase on serum lipoproteins and ubiquinone-10-levels in patients with familial hypercholesterolemia. N. Engl. J. Med. 305, 478–482 (1981).
There are too many friends and colleagues who have contributed to this work over the years to name them individually, but special thanks must go to M. Kuroda for his key role in searching for HMG-CoA reductase inhibitors, to N. Kitano for collaborating in evaluating compactin in hens, dogs and monkeys, and to A. Yamamoto, who first gave compactin to a patient with severe hypercholesterolemia. I am greatly indebted to J. Goldstein and M. Brown, whose friendship and expertise have proved so valuable during my career. And finally, I would like to express my deep gratitude to the Lasker Foundation for the honor of being distinguished with such a prestigious award, which I share with all the members of my laboratories at both Sankyo and Tokyo Noko University.
About this article
Cite this article
Endo, A. A gift from nature: the birth of the statins. Nat Med 14, 1050–1052 (2008). https://doi.org/10.1038/nm1008-1050
This article is cited by
Fungal Diversity (2023)
Pyranocarbazole alkaloids, isolated from Clausena cambodiana leaves, as a pancreatic cholesterol esterase inhibitor, and their HPLC–DAD quantitative determination method
Chemical Papers (2021)
Scientific Reports (2020)
LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia
Lipids in Health and Disease (2018)